Richard J. Daly Submits Initial SEC Ownership Filing for Aquestive Therapeutics
Alpha Vantage · Kalkine Media · · AI-summarised by FinFlash
Richard J. Daly, a Director at Aquestive Therapeutics, Inc. (NASDAQ: AQST), has filed his initial SEC Statement of Beneficial Ownership. The filing, dated October 16, 2026, indicates that Daly holds no common stock directly or indirectly, and no derivative securities in the company as of October 15, 2026. This disclosure marks his initial ownership position upon joining the board.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.